Exercise holds significant importance equal to medication in curbing the reappearance of colon cancer.
In the ever-evolving world of healthcare, colorectal cancer remains a persistent issue, with it being the third most common cancer globally. Research Mongers reveal that a staggering 10% of all cancer cases are colorectal cancer, making it a significant concern.
Recently, Canadian scientists spearheaded a study, published in the esteemed New England Journal of Medicine (NEJM), that compared the effects of a structured exercise program against drug treatments in preventing colon cancer recurrence.
The study, part of the Colon Health and Lifelong Exercise Change (CHALLENGE) trial, involved 889 participants hailing from various countries such as Canada, Australia, the United States, the U.K., and France. The participants had undergone surgery for stage 3 or high-risk stage 2 colon cancer, followed by adjuvant chemotherapy to minimize the chances of the cancer returning. Their ages ranged from 19 to 84 years, with a median age of 61.
Most participants were overweight or obese, and none exercised regularly before the trial. Researchers divided the participants into two groups — the exercise group and the health-education group. The humble ambition of the exercise group was to achieve the equivalent of 3-4 brisk 45-60-minute walks per week with guidance from certified physical activity consultants.
After 7.9 years, the study found that the exercise group had a 28% lower risk of cancer recurrence compared to the health-education group, and a 37% lower risk of death from any cause. Interestingly, experts have commented that the benefits of exercise might exceed that of some drugs, offering a healthier, side-effect-free approach to cancer prevention.
The leading author of the study, Kerry S. Courneya, emphasized the overall improvement in survival as the most significant finding. While the benefits of exercise should not replace drug treatments, it's apparent that exercise offers additional, life-changing benefits like improved physical functioning and a reduced risk of secondary cancers.
Adding a touch of practicality, Courneya noted that the intervention was comparatively cost-effective, with costs ranging from 3,000 to 5,000 Canadian dollars, significantly lower than the costs associated with some cancer drugs.
Support systems are vital to ensure people engage in regular exercise, and obtaining tailored support can be a game-changer. Despite the proven benefits, integrating exercise programs into cancer care remains a challenge due to the resource requirements and the question of patient willingness.
Looking forward, researchers and healthcare providers must collaborate to embed exercise into treatment plans, providing regular support, and encouraging the prescription of exercise as a critical aspect of post-cancer care. By doing so, we can help patients lead healthier, more fulfilling lives and reduce the risk of cancer recurrence.
- In the realm of oncology, colorectal cancer continues to be a significant medical condition, accounting for 10% of all cancer cases worldwide.
- The field of medicine is actively exploring fitness and exercise as potential ways to prevent colorectal cancer recurrence.
- A recent study, conducted by Canadian scientists and published in the New England Journal of Medicine, compared the effects of structured exercise programs against drug treatments in preventing colon cancer recurrence.
- This study, known as the Colon Health and Lifelong Exercise Change (CHALLENGE) trial, involved participants from various countries and age groups, with the majority being overweight or obese.
- The findings of the study revealed that the exercise group had a 28% lower risk of cancer recurrence and a 37% lower risk of death from any cause compared to the health-education group.
- As a result, experts have suggested that the benefits of exercise might exceed those of some drugs, offering a healthier, side-effect-free approach to cancer prevention, fostering a stronger emphasis on health-and-wellness, fitness-and-exercise, and science in cancer care.